Quintás-Cardama A - Search Results

1

The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1.

Pan J, Quintás-Cardama A, Manshouri T, Giles FJ, Lamb P, Tefferi A, Cortes J, Kantarjian H, Verstovsek S. Pan J, et al. Leukemia. 2007 Jul;21(7):1395-404. doi: 10.1038/sj.leu.2404714. Epub 2007 May 10. Leukemia. 2007. PMID: 17495975

2

A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis.

Quintás-Cardama A, Tong W, Kantarjian H, Thomas D, Ravandi F, Kornblau S, Manshouri T, Cortes JE, Garcia-Manero G, Verstovsek S. Quintás-Cardama A, et al. Leukemia. 2008 May;22(5):965-70. doi: 10.1038/leu.2008.91. Epub 2008 Apr 3. Leukemia. 2008. PMID: 18385750 Free PMC article. Clinical Trial.

3

Activity of tyrosine kinase inhibitors against human NUP214-ABL1-positive T cell malignancies.

Quintás-Cardama A, Tong W, Manshouri T, Vega F, Lennon PA, Cools J, Gilliland DG, Lee F, Cortes J, Kantarjian H, Garcia-Manero G. Quintás-Cardama A, et al. Leukemia. 2008 Jun;22(6):1117-24. doi: 10.1038/leu.2008.80. Epub 2008 Apr 10. Leukemia. 2008. PMID: 18401417

4

Bosutinib for the treatment of chronic myeloid leukemia in chronic phase.

Quintás-Cardama A, Kantarjian H, Cortes J. Quintás-Cardama A, et al. Drugs Today (Barc). 2012 Mar;48(3):177-88. doi: 10.1358/dot.2012.48.3.1750274. Drugs Today (Barc). 2012. PMID: 22462037 Review.

5

Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells.

Verstovsek S, Giles FJ, Quintás-Cardama A, Manshouri T, Huynh L, Manley P, Cortes J, Tefferi A, Kantarjian H. Verstovsek S, et al. Leuk Res. 2006 Dec;30(12):1499-505. doi: 10.1016/j.leukres.2006.03.012. Epub 2006 May 8. Leuk Res. 2006. PMID: 16682077

6

Kinase inhibitors in chronic myelogenous leukemia.

Quintás-Cardama A, Cortes J. Quintás-Cardama A, et al. Clin Adv Hematol Oncol. 2006 May;4(5):365-74. Clin Adv Hematol Oncol. 2006. PMID: 16728945

7

Effects of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, on human mast cells bearing wild-type or mutated codon 816 c-kit.

Verstovsek S, Akin C, Manshouri T, Quintás-Cardama A, Huynh L, Manley P, Tefferi A, Cortes J, Giles FJ, Kantarjian H. Verstovsek S, et al. Leuk Res. 2006 Nov;30(11):1365-70. doi: 10.1016/j.leukres.2006.04.005. Epub 2006 Jun 23. Leuk Res. 2006. PMID: 16797704

8

Chronic myeloid leukemia: diagnosis and treatment.

Quintás-Cardama A, Cortes JE. Quintás-Cardama A, et al. Mayo Clin Proc. 2006 Jul;81(7):973-88. doi: 10.4065/81.7.973. Mayo Clin Proc. 2006. PMID: 16835977 Review.

9

EXEL-0862, a novel tyrosine kinase inhibitor, induces apoptosis in vitro and ex vivo in human mast cells expressing the KIT D816V mutation.

Pan J, Quintás-Cardama A, Kantarjian HM, Akin C, Manshouri T, Lamb P, Cortes JE, Tefferi A, Giles FJ, Verstovsek S. Pan J, et al. Blood. 2007 Jan 1;109(1):315-22. doi: 10.1182/blood-2006-04-013805. Epub 2006 Aug 15. Blood. 2007. PMID: 16912224 Free article.

10

Novel approaches in the treatment of systemic mastocytosis.

Quintas-Cardama A, Aribi A, Cortes J, Giles FJ, Kantarjian H, Verstovsek S. Quintas-Cardama A, et al. Cancer. 2006 Oct 1;107(7):1429-39. doi: 10.1002/cncr.22187. Cancer. 2006. PMID: 16948123 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters